--- title: "Toxicology Services - Drug and Alcohol Testing" ocid: "ocds-h6vhtk-058ae7" canonical_url: "https://d3tenders.com/contract/?ocid=ocds-h6vhtk-058ae7" markdown_url: "https://d3tenders.com/contract/ocds-h6vhtk-058ae7.md" json_url: "https://d3tenders.com/contract/ocds-h6vhtk-058ae7.json" source: "Find A Tender Service" current_stage: "Planning" buyer: "GENERAL PHARMACEUTICAL COUNCIL" published: "2025-08-20" --- # Toxicology Services - Drug and Alcohol Testing Buyer: GENERAL PHARMACEUTICAL COUNCIL Current stage: Planning OCID: ocds-h6vhtk-058ae7 [View canonical contract page](https://d3tenders.com/contract/?ocid=ocds-h6vhtk-058ae7) [Download OCDS JSON](https://d3tenders.com/contract/ocds-h6vhtk-058ae7.json) ## Summary The General Pharmaceutical Council is currently at the planning stage of a procurement process for the provision of Toxicology Services, specifically focusing on drug and alcohol testing. This procurement looks to support investigations and ensure participants adhere to conditions set forth during medical assessments. As a central government authority, headquartered in London, the GPhC is calling for interested suppliers to submit response forms by 17:00 on 2nd September 2025. This tender, ID GPhC145, falls within the services category and employs an open competition procurement method, with key dates for submission ending on 10th November 2025. The procurement aims to be formally announced in October 2025 and address various locations across Great Britain. This tender represents significant opportunities for businesses involved in laboratory services, medical analysis, and expert witness services. Companies with expertise in providing phlebotomist and specimen collector support, as well as those skilled in conducting comprehensive blood, alcohol, and drug tests, can leverage this tender to grow their business presence and connect with a sub-central government authority. With a contract value estimated at £157,000 GBP and suitability for SMEs, this procurement offers the potential for both immediate and renewable business partnerships, spanning up to 6 years under flexible contract terms. Interested suppliers will also have the chance to provide supplementary reports and analysis results, contributing to the advancement of healthcare services in Great Britain. ## Notice The GPhC wishes to inform the market of our intention to procure the provision of Toxicology Services - Drug and Alcohol Testing. Where there are concerns regarding physical or mental health, specifically drug and alcohol misuse, the GPhC may necessitate a Pharmacy Registrant (donor) undergo medical assessment, forming part of a wider Fitness to Practise investigation. In such cases, Toxicology Services (drug and alcohol testing) will be required to ascertain: i. if substance(s), as specified by the GPhC, have been used by the donor. ii. if substance(s), as specified by the GPhC, are being used by the donor. Moreover, a Registrant may also be required to enter a period of 'medical supervision' - monitoring to confirm compliance with any restrictions on their registration. Here, Toxicology Services (drug and alcohol testing) will be required to verify fulfilment of conditions set. The purpose of this notice is to raise awareness of our upcoming Request for Quotation sourcing activity, gauge accurate levels of market interest, and receive feedback on prospective plans/requirements in advance of the formal procurement process; to be announced in October 2025. Scope of services will include, the: 1. Supply of Phlebotomists and Specimen Collectors -throughout Great Britain- to collect donor samples: hair (head and body), nail, saliva, blood and urine. 2. Undertaking of sample drug testing for, but not limited to amphetamines, benzodiazepines, cannabinoids, cocaine, hallucinogens, hypnotic substances, ketamine, mephedrone, methadone, methamphetamines (including MDMA and MDEA), novel psychoactive substances, opiates, opioids, sedatives, steroids and tramadol. 3. Undertaking of sample alcohol -ethanol- testing; including phosphatidyl ethanol (PEth), carbohydrate-deficient transferrin (CDT) and fatty acid ethyl esters (FAEE) biomarkers, and ethyl glucuronide (EtG). 4. Undertaking of liver blood testing, formerly known as liver function tests (LFT). 5. Undertaking of full blood count testing (FBC), including mean corpuscular volume testing (MCV). 6. Secure email provision of sample analysis results within 3 working days; including the provision of supplementary reports which interpret results in an accessible (free from technical jargon, where possible), clear and concise manner. 7. Provision of a Certificate of Analysis (CoA). 8. Provision of testimony in the capacity of an Independent Expert Witness (where donor samples are tested for legal purposes). N.B. the Service Provider remains responsible for ensuring staff are adequately trained to undertake this requirement, if requested. Please note, samples are to be collected at a donors' home residence, or a neutral site as determined by the Service Provider. We kindly ask that all interested suppliers complete and submit this response form to Anna Kitoki, at procurement@pharmacyregulation.org by 17:00 on 02.09.2025. Any interest shown does not constitute a commitment to participate; and failure to show interest does not restrict suppliers from participating in this and/or any other procurement process run by the GPhC. ### Lot Information Lot 1 Renewal: 6 Years (2 Years + 2 Year extension + 2 Year extension) ### Planning Information The GPhC wishes to inform the market of our intention to procure the provision of Toxicology Services - Drug and Alcohol Testing. Where there are concerns regarding physical or mental health, specifically drug and alcohol misuse, the GPhC may necessitate a Pharmacy Registrant (donor) undergo medical assessment, forming part of a wider Fitness to Practise investigation. In such cases, Toxicology Services (drug and alcohol testing) will be required to ascertain: i. if substance(s), as specified by the GPhC, have been used by the donor. ii. if substance(s), as specified by the GPhC, are being used by the donor. Moreover, a Registrant may also be required to enter a period of 'medical supervision' - monitoring to confirm compliance with any restrictions on their registration. Here, Toxicology Services (drug and alcohol testing) will be required to verify fulfilment of conditions set. The purpose of this notice is to raise awareness of our upcoming Request for Quotation sourcing activity, gauge accurate levels of market interest, and receive feedback on prospective plans/requirements in advance of the formal procurement process; to be announced in October 2025. Scope of services will include, the: 1. Supply of Phlebotomists and Specimen Collectors -throughout Great Britain- to collect donor samples: hair (head and body), nail, saliva, blood and urine. 2. Undertaking of sample drug testing for, but not limited to amphetamines, benzodiazepines, cannabinoids, cocaine, hallucinogens, hypnotic substances, ketamine, mephedrone, methadone, methamphetamines (including MDMA and MDEA), novel psychoactive substances, opiates, opioids, sedatives, steroids and tramadol. 3. Undertaking of sample alcohol -ethanol- testing; including phosphatidyl ethanol (PEth), carbohydrate-deficient transferrin (CDT) and fatty acid ethyl esters (FAEE) biomarkers, and ethyl glucuronide (EtG). 4. Undertaking of liver blood testing, formerly known as liver function tests (LFT). 5. Undertaking of full blood count testing (FBC), including mean corpuscular volume testing (MCV). 6. Secure email provision of sample analysis results within 3 working days; including the provision of supplementary reports which interpret results in an accessible (free from technical jargon, where possible), clear and concise manner. 7. Provision of a Certificate of Analysis (CoA). 8. Provision of testimony in the capacity of an Independent Expert Witness (where donor samples are tested for legal purposes). N.B. the Service Provider remains responsible for ensuring staff are adequately trained to undertake this requirement, if requested. Please note, samples are to be collected at a donors' home residence, or a neutral site as determined by the Service Provider. We kindly ask that all interested suppliers complete and submit the response form (please see corresponding Planned Procurement Notice) to Anna Kitoki, at procurement@pharmacyregulation.org by 17:00 on 02.09.2025. Any interest shown does not constitute a commitment to participate; and failure to show interest does not restrict suppliers from participating in this and/or any other procurement process run by the GPhC. ## Key Details | Field | Value | | --- | --- | | Publication source | Find A Tender Service | | Latest notice | https://www.find-tender.service.gov.uk/Notice/050008-2025 | | Notice type | UK3 - Planned Procurement Notice | | Procurement type | Standard | | Procurement category | Services | | Procurement method | Open | | Procurement method details | Below threshold - open competition | | Tender suitability | SME | | Awardee scale | Not specified | | All stages | Planning | ## Dates | Field | Value | | --- | --- | | Publication date | 20 Aug 2025 | | Submission deadline | 10 Nov 2025 | | Future notice date | 20 Oct 2025 | | Award date | Not specified | | Contract period | 5 Feb 2026 - 4 Feb 2028 | | Recurrence | Not specified | ## Values | Field | Value | | --- | --- | | Tender value | £157,000 | | Lots value | £157,000 | | Awards value | Not specified | | Contracts value | Not specified | ## Status | Field | Value | | --- | --- | | Tender status | Planned | | Lots status | Planned | | Awards status | Not specified | | Contracts status | Not specified | ## Buyer | Field | Value | | --- | --- | | Main buyer | GENERAL PHARMACEUTICAL COUNCIL | | Locality | LONDON | | Post town | East London | | Postcode | E14 4QJ | | Country | England | | ITL 1 | TLI London | | ITL 2 | TLI4 Inner London - East | | ITL 3 | TLI42 Tower Hamlets | | Local authority | Tower Hamlets | | Electoral ward | Canary Wharf | | Westminster constituency | Poplar and Limehouse | | Delivery location | Not specified | ## CPV Codes ### Divisions - 38 - Laboratory, optical and precision equipments (excl. glasses) - 71 - Architectural, construction, engineering and inspection services - 85 - Health and social work services ### Codes - 38434520 - Blood analysers - 71319000 - Expert witness services - 71900000 - Laboratory services - 85111810 - Blood analysis services - 85121200 - Medical specialist services - 85148000 - Medical analysis services ## Release History - 20 Aug 2025 at 08:03 - Planning - UK3 - Planned Procurement Notice - https://www.find-tender.service.gov.uk/Notice/050008-2025 - 20 Aug 2025 at 08:01 - Planning - UK2 - Preliminary Market Engagement Notice - https://www.find-tender.service.gov.uk/Notice/050007-2025 ## Documents - https://www.find-tender.service.gov.uk/Notice/050008-2025 20th August 2025 - Planned procurement notice on Find a Tender - https://www.find-tender.service.gov.uk/Notice/050007-2025 20th August 2025 - Preliminary market engagement notice on Find a Tender - https://www.find-tender.service.gov.uk/Notice/Attachment/A-4419 ## Notice URLs - https://www.legislation.gov.uk/ukpga/2023/54/contents - https://www.pharmacyregulation.org ## Provenance This Markdown file is an alternate public rendering of the D3 Tenders contract record. The canonical page is https://d3tenders.com/contract/?ocid=ocds-h6vhtk-058ae7. The underlying structured data is available as OCDS JSON at https://d3tenders.com/contract/ocds-h6vhtk-058ae7.json.